Table 4 Assessed diagnoses stratified by cognitive function
Diagnosis | MMSE ≤ 15 (n = 24) | MMSE > 15 (n = 29) | Total (n = 53) |
|---|---|---|---|
Dementia | 22 (92%) | 12 (41%) | 34 (64%) |
Fall/syncope1 | 13 (54%) | 14 (48%) | 27 (51%) |
Arthritis and musculoskeletal pain2 | 9 (38%) | 14 (48%) | 23 (43%) |
Fracture and injury3 | 8 (33%) | 9 (31%) | 17 (32%) |
Urinary symptoms or incontinence4 | 9 (38%) | 7 (24%) | 16 (30%) |
Depressive/anxiety disorder5 | 4 (17%) | 8 (28%) | 12 (23%) |
Eye problems6 | 6 (25%) | 6 (21%) | 12 (23%) |
Essential hypertension | 4 (17%) | 7 (24%) | 11 (21%) |
Delirium | 7 (29%) | 4 (14%) | 11 (21%) |
Osteoporosis/osteomalacia7 | 5 (21%) | 6 (21%) | 11 (21%) |
Heart disease (apart from atrial fibrillation)8 | 3 (13%) | 8 (28%) | 11 (21%) |
Faecal incontinence/constipation | 6 (25%) | 4 (14%) | 10 (19%) |
Chronic lung disease9 | 1 (4%) | 8 (28%) | 9 (17%) |
Atrial fibrillation | 5 (21%) | 4 (14%) | 9 (17%) |
Acute/chronic kidney disease10 | 4 (17%) | 5 (17%) | 9 (17%) |
Anaemia | 6 (25%) | 3 (10%) | 9 (17%) |
Urinary infection | 5 (21%) | 4 (14%) | 9 (17%) |
Deafness/vertigo | 5 (21%) | 3 (10%) | 8 (15%) |
Stroke/cerebrovascular disease | 4 (17%) | 3 (10%) | 7 (13%) |
‘Other’ nervous systems disorders11 | 1 (4%) | 5 (17%) | 6 (11%) |
Peripheral arterial or venous disease12 | 2 (8%) | 4 (14%) | 6 (11%) |
Drug side effects | 4 (17%) | 1 (3%) | 5 (9%) |
Malignancy13 | 0 | 5 (17%) | 5 (9%) |
Gastro-intestinal disorders14 | 2 (8%) | 3 (10%) | 5 (9%) |
Diabetes | 1 (4%) | 4 (14%) | 5 (9%) |
Mental and behavioural disorders due to alcohol | 0 | 4 (14%) | 4 (8%) |
Chest infection | 2 (8%) | 2 (7%) | 4 (8%) |
Presence of functional implants | 1 (4%) | 2 (7%) | 3 (6%) |
High cholesterol | 2 (8%) | 1 (3%) | 3 (6%) |